2019-001587-30: The ADOPTION Study: AZD1656 in Transplantation with Diabetes tO PromoTe Immune TOleraNce |
|
|
| Not yet recruiting | 2 | 50 | Europe | AZD1656, AZD1656, Tablet | Queen Mary University London, Diabetic Kidney Disease Centre (Barts Health NHS Trust) | renal transplant AND type 2 diabetes, kidney transplantdiabetes, Diseases [C] - Nutritional and Metabolic Diseases [C18] | | | | |
| Completed | 2 | 26 | Europe | AZD1656, Placebo | Queen Mary University of London, AstraZeneca | Type 2 Diabetes, Diabetes Mellitus, Type 2, Renal Transplant, Kidney Transplant; Complications, End Stage Renal Disease | 09/22 | 09/22 | | |
